Details

Autor(en) / Beteiligte

• Vuong, Huy Gia
• Altibi, Ahmed M A
• Abdelhamid, Amr Hesham
• Ngoc, Phuong Uyen Duong
• Quan, Vo Duy
• Tantawi, Mohamed Yousef
• Elfil, Mohamed
• Vu, Tran Le Huy
• Elgebaly, Ahmed
• Oishi, Naoki
• Nakazawa, Tadao
• Hirayama, Kenji
• Katoh, Ryohei
• Huy, Nguyen Tien
• Kondo, Tetsuo

Titel

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review

Ist Teil von

• Oncotarget, 2017-02, Vol.8 (6), p.10637-10649

Ort / Verlag

United States: Impact Journals LLC

Erscheinungsjahr

2017

Quelle

MEDLINE

Beschreibungen/Notizen

• The genetic alterations of papillary thyroid carcinoma (PTC) have been reported to change over the past few decades. We performed this systematic review to further examine the trends and modifications of patient demographic, clinicopathological features and molecular profiles of PTC over time. A literature search was performed within six electronic databases to identify relevant articles. The inclusion criteria were published studies investigating BRAF mutations, RET/PTC rearrangements or RAS mutations in PTCs or classical PTCs. Two teams of reviewers independently screened titles and abstracts of all articles. Full texts of potential articles were read and extracted data were listed and stratified into an excel file according to country, city, institution, and surgical time period. Student t test and Pearson Chi-square were used to analyze the trends of demographic and clinicopathological features of PTC patients and the prevalence of each genetic alteration in individual institutions. From 3139 articles, we included 16 articles for final analysis. Our results showed an increasing trend of BRAF and a decreasing trend of RET/PTC prevalence over time in PTCs and classical PTCs, accompanied by an older age of PTC patients, an increase in proportion of PTMC and less aggressive behaviours of tumours. The demographic and clinicopathological characteristics and molecular profile of PTCs have been changing over the past few decades. These modifications suggest changes in etiologies and risk factors of thyroid cancer that influence the tumorigenesis of PTCs.